GoodRx Care vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: GoodRx Care scores higher on our rubric, 6.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
GoodRx Care beats MEDVi overall, scoring 6.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; MEDVi is $179 first month, then $299/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at market-leading subscription pricing, $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at GoodRx Care and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
GoodRx Care
#44 of 54GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx CareMEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | GoodRx Care | MEDVi |
|---|---|---|
| Why each one | The only GLP-1 prescribing service integrated with the largest prescription discount platform in the US, automatically finding the cheapest pharmacy price for your medication. | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. |
| Our Score | 6.2/10 | 5.7/10 |
| Headline Price | $119/mo subscription + medication | $179 first month, then $299/mo |
| Medication Type | Brand | Both |
| Insurance Accepted | Yes | No |
| Best For | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing, $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #44 | #46 |
| Get started | Visit GoodRx Care | Visit MEDVi |
Pros & Cons Compared
GoodRx Care
Pros
- +2026 subscription rewrite, $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo, one of the cheapest oral semaglutide routes
- +Insurance accepted, GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing, may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
GoodRx Care edges out MEDVi with a score of 6.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; MEDVi is $179 first month, then $299/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving GoodRx Care and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- GoodRx Care vs Maximuspublished $79.99/mo; total not verified
- GoodRx Care vs TMatesfrom $158/mo
- GoodRx Care vs DudeMedsfrom $149/mo
- MEDVi vs Fridays$249/mo month-to-month
- MEDVi vs Eden Health GLP-1from $249/mo
- MEDVi vs Elevate Healthfrom $233/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: GoodRx Care · 6.2/10